Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Indoxyl sulfate precursors encompass L-tryptophan, indole, and indoxyl, which are intermediates in the metabolic pathway leading to the formation of indoxyl sulfate, a uremic toxin. The pathway begins with dietary L-tryptophan, which is converted to indole by gut bacteria. Indole is then converted to indoxyl in the liver, and finally sulfated to form indoxyl sulfate. While indoxyl sulfate is the primary focus due to its toxicity, its precursors, particularly indole, also exhibit biological activity. Alterations in this pathway and the gut microbiome can affect systemic levels of these compounds, impacting kidney health and overall physiology.
Varies depending on the specific precursor and interacting drug. Includes modulation of gut microbiota composition, inhibition of enzymatic activity (tryptophanase, CYP2E1, SULT1A1), and adsorption of downstream metabolites.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Indoxyl Sulfate Precursor.